npj Vaccines

Article	Citations
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity	291
Author Correction: Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores	224
Assessing immunogenicity barriers of the HIV-1 envelope trimer	206
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys	167
Reverse development of vaccines against antimicrobial-resistant pathogens	162
The dengue-specific immune response and antibody identification with machine learning	128
Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines	104
Analyzing atomic force microscopy images of virus-like particles by expectation-maximization	95
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine	91
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle	90
Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection	90
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	86
Mapping global public perspectives on mRNA vaccines and therapeutics	83
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern	74
Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine	72
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants	69
Protein engineering strategies for rational immunogen design	61
Rational development of a combined mRNA vaccine against COVID-19 and influenza	61
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice	56
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year	55
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine	55
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development	55
Antibody responses against influenza A decline with successive years of annual influenza vaccination	54
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen	54
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis	54

Immune response against SARS-CoV-2 variants: the role of neutralization assays	54
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen	54
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex	53
LmCen−/− based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia	52
PfRH5 vaccine; from the bench to the vial	50
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses	50
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum	47
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens	47
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins	46
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition	43
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark	42
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth	42
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens	42
Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax	41
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice	41
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus	41
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	40
A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells	40
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9	39
Mobilizing domestic support for international vaccine solidarity – recommendations for health crisis communication	39
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques	36
Dithranol as novel co-adjuvant for non-invasive dermal vaccination	36
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	35
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery	35
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome	35
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity	34
Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques	34
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine	34
Vaccination of cattle with the Babesia bovis sexual-stage protein HAP2 abrogates parasite transmission by Rhipicephalus microplus ticks	33
Urgency and necessity of Epstein-Barr virus prophylactic vaccines	33
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity	33
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection	33
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets	32
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression	32
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection	32
Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy	32
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers	31
Assessing the impact of mRNA vaccination in chronic inflammatory murine model	31
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis	31
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2	31
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans	30
Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior	29
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform	29
A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice	29
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines	29
A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen	28
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants	28
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy	28
Strep A: challenges, opportunities, vaccine-based solutions, and economics	27
Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany	27

A broadly protective vaccine against cutaneous human papillomaviruses	27
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity	27
Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant	27
Toxoplasmosis vaccines: what we have and where to go?	26
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges	26
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary	26
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants	26
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children	26
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge	26
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein	26
C5aR+ dendritic cells fine-tune the Peyer’s patch microenvironment to induce antigen-specific CD8+ T cells	26
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children	26
mRNA vaccines induce rapid antibody responses in mice	26
The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control	26
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58	25
The Streptococcus pyogenes vaccine landscape	25
Continuing development of vaccines and monoclonal antibodies against Zika virus	25
Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization	24
Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis	24
Analyzing immune responses to varied mRNA and protein vaccine sequences	24
Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees	24
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity	23
Antigen-specific antibody and polyfunctional T cells generated by respiratory immunization with protective Burkholderia ΔtonB Δhcp1 live attenuated vaccines	23
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice	23
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns	23
Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies	23
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine	23
Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice	23
Establishing an immune correlate of protection for Nipah virus in nonhuman primates	23
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection	22
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales	22
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase	22
Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice	22
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19	22
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response	21
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model	21
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness	21
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens	21
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine	21
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection	20
Genetic ancestry and population structure of vaccinia virus	20
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial	20
Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma	20
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	20
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians	20
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population	20
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development	20
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial	20
B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs	20
Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge	20
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses	19
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial	19
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections	19
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial	19
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance	19
A highly immunogenic UVC inactivated Sabin based polio vaccine	19
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG	19
Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge	19
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons	19
Is new dengue vaccine efficacy data a relief or cause for concern?	19
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy	19
NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae	19
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen	19
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants	18
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles	18
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism	18
The scientific journey of a novel adjuvant (AS37) from bench to bedside	18
Oral vaccination stimulates neutrophil functionality and exerts protection in a Mycobacterium avium subsp. paratuberculosis infection model	18
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore	17
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles	17
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein	17
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques	17
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates	17
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus	17
The full health, economic, and social benefits of prospective Strep A vaccination	17
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2	17
Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection	17
Progress with COVID vaccine development and implementation	16
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2	16
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice	16

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines	16
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system	16
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model	16
Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children	15
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic	15
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice	15
The immunological interplay between vaccination and the intestinal microbiota	15
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA	15
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development	15
Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells	15
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging	15
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines	15
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine	15
Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230	15
Author Correction: The dengue-specific immune response and antibody identification with machine learning	15
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort	15
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination	15
Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza	15
A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine	15
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease	14
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination	14
Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice	14
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France	14
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21	14
Optimization of an alum-anchored clinical HIV vaccine candidate	14
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice	14
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults	14
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine	14
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza	14
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates	14
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant	14
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy	13
Applying causal inference and Bayesian statistics to understanding vaccine safety signals using a simulation study	13
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers	13
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame	13
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice	13
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development	13
Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ	13
Filovirus vaccines as a response paradigm for emerging infectious diseases	13
Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease	13
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	13
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2	13
Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model	13
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques	13
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality	13
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans	13
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses	13
A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection	13
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus	13
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data	13
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly	13
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts	13